Hillhouse Investment Management, Ltd. - Jan 25, 2024 Form 3 Insider Report for ArriVent Biopharma, Inc. (AVBP)

Role
10%+ Owner
Signature
Hillhouse Investment Management, Ltd., by: /s/ Audrey Woon, Chief Compliance Officer
Stock symbol
AVBP
Transactions as of
Jan 25, 2024
Transactions value $
$0
Form type
3
Date filed
1/25/2024, 09:01 PM
Previous filing
Oct 27, 2021
Next filing
Feb 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVBP Series A Preferred Stock Jan 25, 2024 Common Stock 3.62 M See footnotes F1, F2, F4
holding AVBP Series B Preferred Stock Jan 25, 2024 Common Stock 313 K See footnotes F1, F3, F4

Explanation of Responses:

Id Content
F1 The preferred stock is convertible into shares of common stock on a 15.21-for-1 basis, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The preferred stock has no expiration date.
F2 The securities reported herein are held by VSUM VI Holdings Limited ("VSUM VI") and VSUM VIII Holdings Limited ("VSUM VIII"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. ("Hillhouse Venture V") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. ("Hillhouse Healthcare"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare.
F3 The securities reported herein are held by VSUM VIII and ARVT Holdings Limited ("ARVT"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. ("Hillhouse Venture VI"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI.
F4 This statement is filed by Hillhouse Investment Management, Ltd., an exempted Cayman Islands company ("HIM" or the "Reporting Person"). The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.